4//SEC Filing
Gaines Kristin Sallee 4
Accession 0001127602-24-007095
CIK 0000877860other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 3:34 PM ET
Size
25.5 KB
Accession
0001127602-24-007095
Insider Transaction Report
Form 4
Gaines Kristin Sallee
Chief Credit Officer
Transactions
- Award
Common Stock
2024-02-23+3,000→ 51,609 total - Award
Stock Option (Right to Buy) 2024
2024-02-23+8,333→ 8,333 totalExercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - Award
Stock Option (Right to Buy) 2024
2024-02-23+8,333→ 8,333 totalExercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - Award
Stock Option (Right to Buy) 2024
2024-02-23+8,334→ 8,334 totalExercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,334 underlying)
Holdings
- 18,334
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (18,334 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2020-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2021-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2022-02-21Exp: 2025-02-21→ Common Stock (18,334 underlying) - 18,333
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - 18,333
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - 18,334
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2023-02-25Exp: 2026-02-25→ Common Stock (18,334 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 8,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (8,334 underlying)
Footnotes (1)
- [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting February 23, 2025.
Documents
Issuer
NATIONAL HEALTH INVESTORS INC
CIK 0000877860
Entity typeother
Related Parties
1- filerCIK 0001455833
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 3:34 PM ET
- Size
- 25.5 KB